Galectin Therapeutics Inc (NASDAQ:GALT)

3.54
Delayed Data
As of Mar 27
 -0.01 / -0.28%
Today’s Change
3.00
Today|||52-Week Range
17.14
+2.02%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Czirr James C
Executive Chairman
Sale1/31/201593,168$3.22$300.0K+9.94%
Czirr James C
Executive Chairman
Buy1/31/2015166,667$1.80$300.0K+9.94%
Martin Rod D
Director
Buy5/13/201483,334$1.80$150.0K-69.54%
Prelack Steven
Director
Sale4/11/20146,000$11.84$71.0K-69.24%
Traber Peter G
President & Chief Executive Officer
Buy8/14/20142,000$4.48$9.0K-23.21%
Traber Peter G
President & Chief Executive Officer
Buy8/14/20142,000$4.44$8.9K-23.21%
Freeman Kevin D
Director
Buy8/15/20141,000$4.70$4.7K-25.94%
Greenberg Arthur R
Director
Buy8/19/20141,000$4.56$4.6K-22.71%
Callicutt Jack W
Chief Financial Officer
Buy8/14/20141,000$4.55$4.6K-23.21%
Traber Peter G
President & Chief Executive Officer
Buy8/13/20141,000$4.42$4.4K-19.18%
Page of 2

To view my watchlist

Not a member yet?

Sign up now for a free account